Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
crispr
3
×
abbvie
alzheimer's disease
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
eli lilly
glaxosmithkline
indiana blog main
indiana top stories
life sciences
merck
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acceleron pharma
acid sphingomyelinase deficiency
adalimumab (humira)
aducanumab
What
companies
3
×
bio
mammoth
roundup
approval
biogen’s
biopharmaceutical
black
breathing
close
colossal
company
continue
convo
create
crispr’s
debut
diamond
diamond’s
drug
earlier
editing
failures
gene
growing
indication
interested
investors
leading
life
littered
living
march
medicine
moves
nash
new
news
number
ohana’s
Language
unset
Current search:
companies
×
crispr
×
@techcrunch.com
2 years ago
How Colossal sold investors on a quest to resurrect a woolly mammoth
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
